Enzychem Lifesciences Statistics

Total Valuation

Enzychem Lifesciences has a market cap or net worth of KRW 102.19 billion. The enterprise value is -8.70 billion.

Market Cap	102.19B
Enterprise Value	-8.70B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Enzychem Lifesciences has 79.84 million shares outstanding. The number of shares has decreased by -26.86% in one year.

Current Share Class	n/a
Shares Outstanding	79.84M
Shares Change (YoY)	-26.86%
Shares Change (QoQ)	-2.25%
Owned by Insiders (%)	5.19%
Owned by Institutions (%)	5.95%
Float	68.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.27
PB Ratio	0.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.98
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.94

Financial Position

The company has a current ratio of 14.43, with a Debt / Equity ratio of 0.02.

Current Ratio	14.43
Quick Ratio	11.64
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.46
Interest Coverage	-52.75

Financial Efficiency

Return on equity (ROE) is -4.71% and return on invested capital (ROIC) is -4.37%.

Return on Equity (ROE)	-4.71%
Return on Assets (ROA)	-4.16%
Return on Capital (ROIC)	-4.37%
Revenue Per Employee	695.30M
Profits Per Employee	-73.08M
Employee Count	122
Asset Turnover	0.41
Inventory Turnover	5.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.46%
50-Day Moving Average	1,472.62
200-Day Moving Average	1,714.14
Relative Strength Index (RSI)	29.29
Average Volume (20 Days)	360,582

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzychem Lifesciences had revenue of KRW 84.83 billion and -8.92 billion in losses. Loss per share was -105.88.

Revenue	84.83B
Gross Profit	5.09B
Operating Income	-13.63B
Pretax Income	-9.43B
Net Income	-8.92B
EBITDA	-10.12B
EBIT	-13.63B
Loss Per Share	-105.88

Full Income Statement

Balance Sheet

The company has 116.35 billion in cash and 4.30 billion in debt, giving a net cash position of 112.05 billion or 1,403.46 per share.

Cash & Cash Equivalents	116.35B
Total Debt	4.30B
Net Cash	112.05B
Net Cash Per Share	1,403.46
Equity (Book Value)	181.70B
Book Value Per Share	2,234.71
Working Capital	149.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.71 billion and capital expenditures -1.54 billion, giving a free cash flow of -9.25 billion.

Operating Cash Flow	-7.71B
Capital Expenditures	-1.54B
Free Cash Flow	-9.25B
FCF Per Share	-115.87

Full Cash Flow Statement

Margins

Gross margin is 6.00%, with operating and profit margins of -16.07% and -10.51%.

Gross Margin	6.00%
Operating Margin	-16.07%
Pretax Margin	-11.12%
Profit Margin	-10.51%
EBITDA Margin	-11.93%
EBIT Margin	-16.07%
FCF Margin	-10.91%

Dividends & Yields

Enzychem Lifesciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	26.86%
Shareholder Yield	26.86%
Earnings Yield	-8.27%
FCF Yield	-9.05%

Stock Splits

The last stock split was on August 17, 2022. It was a forward split with a ratio of 6.

Last Split Date	Aug 17, 2022
Split Type	Forward
Split Ratio	6

Scores

Enzychem Lifesciences has an Altman Z-Score of 7.83.

Altman Z-Score	7.83
Piotroski F-Score	n/a